DBV Technologies SA appointed Michel de Rosen to its board of directors.
De Rosen is replacing George Horner III, who resigned from the board in December 2017. De Rosen's appointment will be proposed at DBV's general meeting June 22.
The Montrouge, France-based company's board comprises eight directors following de Rosen's appointment.
De Rosen previously held the chairman and CEO posts at Eutelsat, ViroPharma and Rhône-Poulenc Santé.
DBV is a clinical-stage biopharmaceutical company focused on developing a technology platform with broad potential applications in immunotherapy.